VERTEBROBASILAR DOLICHOECTASIA
Clinical trials for VERTEBROBASILAR DOLICHOECTASIA explained in plain language.
Never miss a new study
Get alerted when new VERTEBROBASILAR DOLICHOECTASIA trials appear
Sign up with your email to follow new studies for VERTEBROBASILAR DOLICHOECTASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common drug tame a rare brain artery disorder?
Disease control Not yet recruitingThis pilot trial tests whether sirolimus, an anti-inflammatory drug, can reduce artery wall swelling in people with vertebrobasilar dolichoectasia (VBD), a condition where arteries at the base of the brain become enlarged and twisted. Twelve participants will take sirolimus daily…
Matched conditions: VERTEBROBASILAR DOLICHOECTASIA
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common blood pressure drug tame a rare brain artery disorder?
Disease control Not yet recruitingThis pilot study tests whether amiloride, a drug used for high blood pressure, can reduce inflammation in the walls of enlarged arteries at the base of the brain in people with vertebrobasilar dolichoectasia (VBD). Six adults with VBD will take amiloride for up to 12 months. Rese…
Matched conditions: VERTEBROBASILAR DOLICHOECTASIA
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC